Upper reference limits for aminotransferase activities and the prevalence of elevated aminotransferase activities in a Korean population

Journal of Clinical Gastroenterology

Volumn 47, Issue 1, 2013, Pages 76-82

  Park, Seung Ha ^a   Heo, Nae Yun ^a   Kim, Chang Hoon ^b   Suk, Ki Tae ^c   Kim, Dong Joon ^c   Lee, Heon Young ^d  

^a Inje University College of Medicine   (South Korea)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

^c Hallym University College of Medicine   (South Korea)

^d Chungnam National University College of Medicine   (South Korea)

Author keywords

alanine aminotransferase; aspartate aminotransferase; upper reference limit

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; CARBOHYDRATE; CHOLESTEROL; GLUCOSE; HEPATITIS B ANTIGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARBOHYDRATE METABOLISM; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CONTROLLED STUDY; DRUG USE; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; KOREA; LIPID BLOOD LEVEL; LIPID METABOLISM; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NUTRITION; PREVALENCE; PRIORITY JOURNAL; REFERENCE VALUE; RISK FACTOR; SEX RATIO; TREND STUDY; TRIACYLGLYCEROL BLOOD LEVEL; UPPER REFERENCE LIMIT; WAIST CIRCUMFERENCE;

ADULT; ALANINE TRANSAMINASE; ASIAN CONTINENTAL ANCESTRY GROUP; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; LIVER DISEASES; MALE; NUTRITION SURVEYS; PREVALENCE; REFERENCE VALUES; REPUBLIC OF KOREA; RISK FACTORS;

EID: 84871614588     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31825752a4     Document Type: Article

References (29)

1. Park SH. Implication of liver enzymes in viral and alcoholic liver diseases. Korean J Hepatol. 2011;17:237-242.
2. Kim WR, Flamm SL, Di Bisceglie AM, et al. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology. 2008;47:1363-1370.
3. Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137:1-10.
4. Lee JK, Shim JH, Lee HC, et al. Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology. Hepatology. 2010;51:1577-1583.
5. Kingma E. What is it to be healthy? Analysis. 2007;67:128-133.
6. Neuschwander-Tetri BA, Unalp A, Creer MH. Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels. Arch Intern Med. 2008;168:663-666.
7. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98:960-967.
8. Ioannou GN, Boyko EJ, Lee SP. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol. 2006;101:76-82.
9. The Korean Association for Survey Research. Sampling Design of the 4th (2007-2009) KNANES. Available at: http://knhanes. cdc. go. kr/. Accessed at February 22, 2011.
10. Chitturi S, Wong VW, Farrell G. Nonalcoholic fatty liver in Asia: firmly entrenched and rapidly gaining ground. J Gastroenterol Hepatol. 2011;26:163-172.
11. Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology. 2002;123:1367-1384.
12. Schenker N, Gentleman JF. On judging the significance of differences by examining the overlap between confidence intervals. Am Stat. 2001;55:182-186.
13. Kang HS, Um SH, Seo YS, et al. Healthy range for serum ALT and the clinical significance of "unhealthy" normal ALT levels in the Korean population. J Gastroenterol Hepatol. 2011; 26:292-299.
14. Wejstal R, Hansson G, Lindholm A, et al. Persistent alanine aminotransferase elevation in healthy Swedish blood donors-mainly caused by obesity. Vox Sang. 1988;55:152-156.
15. Piton A, Poynard T, Imbert-Bismut F, et al. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. Hepatology. 1998;27:1213-1219.
16. Ruhl CE, Everhart JE. Upper limits of normal for alanine aminotransferase activity in the United States population. Hepatology. 2012;55:447-454.
17. Kim WR, Bambha K, Pedersen RA, et al. Impact of new upper limits of normal for alanineaminotransferase in the US population. Hepatology. 2007;46:745A.
18. Kaplan MM. Alanine aminotransferase levels: what's normal? Ann Intern Med. 2002;137:49-51.
19. Adams LA, Knuiman MW, Divitini ML, et al. Body mass index is a stronger predictor of alanine aminotransaminase levels than alcohol consumption. J Gastroenterol Hepatol. 2008;23:1089-1093.
20. Park SH, Kim BI, Yun JW, et al. Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. J Gastroenterol Hepatol. 2004;19:694-698.
21. Park SH, Kim BI, Kim SH, et al. Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men. J Am Coll Nutr. 2007;26:321-326.
22. Ruhl CE, Everhart JE. Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. Clin Gastroenterol Hepatol. 2005;3: 1260-1268.
23. Beranek M, Drsata J, Palicka V. Inhibitory effect of glycation on catalytic activity of alanine aminotransferase. Mol Cell Biochem. 2001;218:35-39.
24. Panteghini M. Aspartate aminotransferase isoenzymes. Clin Biochem. 1990;23:311-319.
25. Nalpas B, Vassault A, Le Guillou A, et al. Serum activity of mitochondrial aspartate aminotransferase: a sensitive marker of alcoholism with or without alcoholic hepatitis. Hepatology. 1984;4:893-896.
26. Zhou SL, Gordon RE, Bradbury M, et al. Ethanol upregulates fatty acid uptake and plasma membrane expression and export of mitochondrial aspartate aminotransferase in HepG2 cells. Hepatology. 1998;27:1064-1074.
27. Kim HC, Nam CM, Jee SH, et al. Normal serum aminotransferase concentrationand risk of mortality from liver diseases: prospective cohort study. BMJ. 2004;328:983.
28. Goessling W, Massaro JM, Vasan RS, et al. Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology. 2008;135: 1935-1944, 44 e1.
29. Fraser CG. Biological variation in clinical chemistry. An update: collated data, 1988-1991. Arch Pathol Lab Med. 1992; 116:916-923.